Acute severe status asthmaticus: ventilation, anaesthesia, and refractory bronchospasm

Also known as Status asthmaticus · Near-fatal asthma · Refractory asthma · Asthma ventilation · Volatile anaesthesia for asthma · Permissive hypercapnia · Dynamic hyperinflation

Status asthmaticus = severe asthma unresponsive to standard bronchodilator therapy — life-threatening. CLINICAL: silent chest, normal or rising PaCO2, PEFR under 25% of personal best with failed response to frequent bronchodilators and intravenous steroids. FIRST LINE: oxygen, repeated nebulised salbutamol + ipratropium (continuous nebulisation also supported over intermittent) early systemic corticosteroids. SECOND LINE: IV magnesium 2 g over 20 min for poor responders. VENTILATION (CRITICAL): controlled hypoventilation — deliberately low minute ventilation (low rate, small tidal volume, high inspiratory flow, long expiratory time), correcting hypoxaemia without chasing normocapnia, to avoid DYNAMIC HYPERINFLATION (the killer: hypotension, barotrauma and arrhythmias in ventilated asthmatics). If hypotension follows ventilation: reduce or briefly pause ventilation and allow full exhalation. REFRACTORY: volatile anaesthetics (sevoflurane/isoflurane via anaesthetic machine — improvement typically within 1-2 h), heliox-driven nebulisation, VV-ECMO (83.5% survival in the ELSO registry).

high26 referencesUpdated 13 Oct 202620 min readSource-verified · Oct 2026

Checked against its sources on 13 Oct 2026

Practise this topic

8 MCQs

In one line

Status asthmaticus is the most severe subset of asthma exacerbations — severe asthma unresponsive to standard bronchodilator therapy. The killer on the ventilator is dynamic hyperinflation (breath-stacking) — hypotension, barotrauma and arrhythmias in severe asthma occur almost exclusively in patients who have been mechanically ventilated. Ventilate with controlled hypoventilation: deliberately low minute ventilation (low rate, small tidal volume, high inspiratory flow, long expiratory time), correcting hypoxaemia with oxygen-rich mixtures without trying to restore normal alveolar ventilation. If the blood pressure falls after ventilation starts or the rate rises, reduce or briefly pause ventilation and let the patient exhale fully. Escalate pharmacologically in parallel: repeated nebulised salbutamol + ipratropium (continuous nebulisation also supported over intermittent) → early systemic steroids → IV magnesium 2 g over 20 min for poor responders → volatile anaesthetics for refractory bronchospasm → VV-ECMO as last resort.

^[1] ^[2] ^[3] ^[5] ^[8] ^[9] ^[20] ^[26]

Meet the patient

It is 3 am on the medical ICU. A 28-year-old woman with known severe asthma is brought in by her partner after six hours of progressive breathlessness. She has had three back-to-back salbutamol-ipratropium nebulisers, an intravenous corticosteroid and IV magnesium 2 g in the emergency department, and is getting worse. From the door she cannot speak; the chest is silent on auscultation. SpO2 is 88 percent on 15 L/min via non-rebreather; respiratory rate 32. Arterial blood gas: pH 7.18, PaCO2 58 mmHg (it was 32 ninety minutes ago), PaO2 64 mmHg, bicarbonate 22. The inability to speak with a failed response to frequent bronchodilators plus intravenous steroids is the criterion set that marks out critical asthma syndrome for emergency care and, usually, intensive care. ^[1]

The two questions that decide her next hour are the two that decide every status asthmaticus: is the airway about to be lost? (silent chest on a tiring patient with a rising CO2 says yes — intubate before the arrest, not at it) and will the ventilator kill her if it is set wrong? (yes — hyperinflation will; controlled hypoventilation will not). In the original controlled-hypoventilation series, ten of the twenty-six ventilated patients were already in coma and five in respiratory arrest at the moment of intubation — the lesson is to act one step earlier. ^[1]^[3]

References26Show

[1]Schivo M, Phan C, Louie S, et al. Critical asthma syndrome in the ICU. Clinical reviews in allergy & immunology, 2015.PMID 25759905
[2]Leatherman J Mechanical ventilation for severe asthma. Chest, 2015.PMID 26033128
[3]Darioli R, Perret C Mechanical controlled hypoventilation in status asthmaticus. American review of respiratory disease, 1984.PMID 6703497
[4]Tuxen DV, Lane S The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. American review of respiratory disease, 1987.PMID 3662241
[5]Williams TJ, Tuxen DV, Scheinkestel CD, et al. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. American review of respiratory disease, 1992.PMID 1519836
[6]Tuxen DV, Williams TJ, Scheinkestel CD, et al. Use of a measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma. American review of respiratory disease, 1992.PMID 1443862
[7]Menitove SM, Goldring RM Combined ventilator and bicarbonate strategy in the management of status asthmaticus. American journal of medicine, 1983.PMID 6837612
[8]Lalloo UG, Ainslie GM, Abdool-Gaffar MS, et al. Guideline for the management of acute asthma in adults: 2013 update. South African medical journal, 2012.PMID 23656743
[9]Goodacre S, Cohen J, Bradburn M, et al. The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma. Health technology assessment, 2014.PMID 24731521
[10]Goodacre S, Cohen J, Bradburn M, et al. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial. Lancet respiratory medicine, 2013.PMID 24429154
[11]Powell C, Kolamunnage-Dona R, Lowe J, et al. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial. Lancet respiratory medicine, 2013.PMID 24429155
[12]Kew KM, Kirtchuk L, Michell CI Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane database of systematic reviews, 2014.PMID 24865567
[13]Travers AH, Jones AP, Camargo CA Jr, et al. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane database of systematic reviews, 2012.PMID 23235686
[14]Ho GWK, Thaarun T, Ee NJ, et al. A systematic review on the use of sevoflurane in the management of status asthmaticus in adults. Critical care, 2024.PMID 39402635
[15]Gorsky K, Cuninghame S, Jayaraj K, et al. Inhaled volatiles for status asthmaticus, epilepsy, and difficult sedation in adult ICU and PICU: a systematic review. Critical care explorations, 2024.PMID 38384587
[16]Shankar V, Churchwell KB, Deshpande JK Isoflurane therapy for severe refractory status asthmaticus in children. Intensive care medicine, 2006.PMID 16614808
[17]Yeo HJ, Kim D, Jeon D, et al. Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry. Critical care, 2017.PMID 29212551
[18]Rodrigo GJ, Castro-Rodriguez JA Heliox-driven beta2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Annals of allergy, asthma & immunology, 2014.PMID 24331390
[19]Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane database of systematic reviews, 2006.PMID 17054154
[20]Mein SA, Ferrera MC Management of asthma and COPD exacerbations in adults in the ICU. CHEST critical care, 2025.PMID 40330435
[21]Phoophiboon V, Singhagowinta P, Boonkaya S, et al. Salbutamol-induced lactic acidosis in status asthmaticus survivor. BMC pulmonary medicine, 2021.PMID 33435939
[22]Aslam SM, Shyllesh HA, Siddarth TsV, et al. Inadvertent salbutamol overdose presenting as acute toxicity. Cureus, 2025.PMID 41287681
[23]Wasserfallen JB, Schaller MD, Feihl F, et al. Sudden asphyxic asthma: a distinct entity? American review of respiratory disease, 1990.PMID 2368957
[24]Nates JL, Cooper DJ, Day B, et al. Acute weakness syndromes in critically ill patients -- a reappraisal. Anaesthesia and intensive care, 1997.PMID 9352763
[26]Camargo CA Jr, Spooner CH, Rowe BH Continuous versus intermittent beta-agonists in the treatment of acute asthma. The Cochrane database of systematic reviews, 2003.PMID 14583926
[25]Khedher A, Meddeb K, Sma N, et al. Pulmonary barotrauma including huge pulmonary interstitial emphysema in an adult with status asthmaticus. European journal of case reports in internal medicine, 2018.PMID 30756032